D61.2 ICD-10-CM Code: Aplastic anemia due to other external agents
Compare with another codeCheck this code on a claim
Billing Status: YES. This is a valid, specific, and billable ICD-10-CM reference.
Coding at a Glance
- Tabular directives
- 1 Excludes2 · 1 code-first instruction
Billable · FY2027A valid, specific ICD-10-CM code, reportable for dates of service in FY2027.
What you need to know
Source: CMS/NCHS Official ICD-10-CM tabular notes, quoted. From the CMS/NCHS tabular list for the release in force. A note the category or block publishes applies to this code too; the Instructions section marks which is which.
- Code firstSequence the underlying condition before this code
- , if applicable, toxic effects of substances chiefly nonmedicinal as to source (T51-T65)
- Excludes2Not included here; may be reported together
- neutropenia (D70.-)
Most relevant related codes MedCoder-derived
Read off the official notes above and this code’s own position in the tabular list. Which to report is a documentation question; Compare shows the two side by side.
Inpatient Payment Groups (MS-DRG)
Potential MS-DRG participation — not a DRG assignment.
MS-DRGs this diagnosis helps define, as principal or secondary, per the CMS ICD-10-CM/PCS MS-DRG Definitions Manual v44, Appendix B.
- MS-DRG 808 — MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MCC (MDC 16)
- MS-DRG 809 — MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH CC (MDC 16)
- MS-DRG 810 — MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT CC/MCC (MDC 16)
A diagnosis appearing in a group's logic does not by itself determine the DRG assigned to a stay; the grouper uses the full claim.
Risk Adjustment (CMS-HCC)
Payment categories this diagnosis maps to under CMS-HCC V28, payment year 2026.
- HCC 109 — Acquired Hemolytic, Aplastic, and Sideroblastic Anemias
Other models: CMS-HCC V22 HCC 46 · RxHCC V08 HCC 96
Risk scores depend on the enrollee's full accepted diagnosis set and segment; a category mapping alone does not determine payment.
Coding instructions
Official Tabular Instructional Notes: the inclusion, exclusion and sequencing notes published for D61.2 in the official ICD-10-CM tabular list, quoted as published.
Source: CMS/CDC — ICD-10-CM Tabular ListRelease: FY2027Effective: October 1, 2026
Trace:FY2027 changesChange historyRelease, file and checksum
Notes without a marker are published on D61.2 itself; “inherited from” names the category or block whose note applies here.
Excludes2 — Not Included Here
Conditions not covered by this code, but which may be reported alongside it when both are present.
- neutropenia (D70.-) Compare D61.2 vs D70 →
Source: inherited from D61
Code First
Underlying conditions that must be sequenced before this code.
- Code first, if applicable, toxic effects of substances chiefly nonmedicinal as to source (T51-T65)
Coder workflow for D61.2
MedCoder structured workflow — derived from this code’s own official record
Before you code D61.2
- D61.2’s title joins a condition with an associated condition or complication. Confirm each component is documented. Where the classification presumes the link through the “with” convention, only a provider statement that the conditions are unrelated defeats it. A combination code is assigned only when it fully identifies the documented conditions; a required second code for the stage, type or manifestation is still reported when the notes ask for it (Guidelines I.B.9, I.A.15).
Choose the right path
- Is the underlying (etiologic) condition the Code First note names documented?
Yes → Sequence the underlying condition first, then D61.2.
No → Continue; do not add an underlying condition the record does not document.
Consider D61.2. Then confirm the code is valid for the date of service in the Verify section.
Documentation check
- The provider’s diagnostic statement
- Codes are assigned from the provider’s documented diagnosis, not from clinical criteria, test values or a medication list (Guidelines I.A.19).
- The associated condition or complication
- Whether the associated condition the title names is documented; the “with” convention presumes some links, and a provider statement that the conditions are unrelated defeats it (Guidelines I.A.15).
- The underlying (etiologic) condition
- Named in the Code First note; sequenced before this code when documented (Guidelines I.A.13).
Official instructions as workflow
Excludes2 — not part of D61.2(1 note)
Coding workflow: The conditions named in this note are not included in D61.2. When the record documents both, both may be reported; the note is a boundary, not a prohibition.
CompareD70
See the official tabular notes · Guidelines I.A.12.b
Code First — sequencing check(1 note)
Coding workflow: Check whether the underlying or etiologic condition the note names is documented. When it is, sequence it before D61.2. Do not add an underlying condition the record does not document.
See the official tabular notes · Guidelines I.A.13
Coding decision scenarios
Pattern scenarios for this code’s structure — decision rules, not clinical cases
Documentation: Only one of the components this code’s title joins is documented.
Coding question: Is D61.2 supported?
Path: Review the code for the documented component on its own.
Reason: A combination code is assigned only when it fully identifies the documented conditions; otherwise the documented component takes its own code (Guidelines I.B.9).
Documentation: The underlying condition the Code First note names is documented alongside this condition.
Coding question: How are the two sequenced?
Path: Review the Code First note.
Reason: The underlying condition is sequenced first and the manifestation follows (Guidelines I.A.13).
Every row is derived from this code’s own record — its title, tabular notes, 7th-character family and same-category siblings — with fixed MedCoder wording; nothing is inferred about a patient. The official notes and guideline text are in the sections each row links to, and they control.
Coding context
Guidelines, coding notes, decision aids, relationships (with MS-DRG and CCSR classification), hierarchy, HCC, coverage and the context map: what a coder reaches for after the core. Each section names whether it is official source data, a MedCoder-derived relationship or MedCoder editorial.
Code Overview
MedCoder summary Summary composed by MedCoder from this code's official ICD-10-CM record. The tabular instructional notes themselves appear verbatim below.
Official Coding Guidelines
No excerpt in the ICD-10-CM Official Guidelines names this code specifically. Its chapter carries only this chapter-wide note:
Chapter 3: Disease of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)
Reserved for future guideline expansion
Verify Before Coding
- MCC as a secondary diagnosis (FY2027). Can raise the stay's MS-DRG severity tier.
From the code registry, the Medicare Code Editor, and the MS-DRG Definitions Manual. Check it against a full claim in Claim Check.
Relationships & Classification
MedCoder-derived relationships — computed from published CMS and AHRQ datasets
Other codes that name D61.2 or its code family, from the CMS ICD-10-CM tabular instructional notes. Tabular-note edges are stored at the code family level that carries each note.
Referenced by 1 Excludes1 note: R71 — Abnormality of red blood cells (via D61.-).
These codes’ tabular lists mark this diagnosis as mutually exclusive — not reported together unless the conditions are documented as unrelated.
Referenced by 23 Code First instructions across 3 chapters: I21.A1 — Myocardial infarction type 2 (via D61.-), M90.5 — Osteonecrosis in diseases classified elsewhere (via D61.-), T36 — Poisoning by, adverse effect of and underdosing of systemic antibiotics (via D61.-), T36-T39 — Antibiotics & Anti-infectives (T36-T39) (via D61.-), T36-T50 — Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50) (via D61.-), T37 — Poisoning by, adverse effect of and underdosing of other systemic anti-infectives and antiparasitics (via D61.-), T38 — Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified (via D61.-), T39 — Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics (via D61.-), T40 — Poisoning by, adverse effect of and underdosing of narcotics and psychodysleptics [hallucinogens] (via D61.-), T40-T41 — Analgesics & Antipyretics (T40-T41) (via D61.-), T41 — Poisoning by, adverse effect of and underdosing of anesthetics and therapeutic gases (via D61.-), T42 — Poisoning by, adverse effect of and underdosing of antiepileptic, sedative- hypnotic and antiparkinsonism drugs (via D61.-), T42-T43 — Anticonvulsants & Psychotropics (T42-T43) (via D61.-), T43 — Poisoning by, adverse effect of and underdosing of psychotropic drugs, not elsewhere classified (via D61.-), T44 — Poisoning by, adverse effect of and underdosing of drugs primarily affecting the autonomic nervous system (via D61.-), T44-T46 — Cardiovascular & Gastrointestinal (T44-T46) (via D61.-), T45 — Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified (via D61.-), T46 — Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system (via D61.-), T47 — Poisoning by, adverse effect of and underdosing of agents primarily affecting the gastrointestinal system (via D61.-), T47-T50 — Hormones & Systemic Agents (T47-T50) (via D61.-), +3 more.
Each of these codes carries a Code First note naming this condition — when that code is reported, THIS code is sequenced first, ahead of it.
MS-DRG Grouper Relationships (FY2027)
Potential MS-DRG participation — not a DRG assignment.
FY2027 MS-DRG: MCC — Major Complication or Comorbidity. Reported as a secondary diagnosis, this code raises the stay's MS-DRG severity tier — except when the principal diagnosis is one of 110 clinically related codes on its CMS exclusion list.
Named in the grouper logic of 3 MS-DRGs: DRG 808 (MDC 16), DRG 809 (MDC 16), DRG 810 (MDC 16).
From the CMS MS-DRG Definitions Manual (Appendices B and C). Actual DRG assignment depends on the complete claim.
Clinical classification (AHRQ CCSR):INJ030 — Drug induced or toxic related condition (default); BLD003 — Aplastic anemia.
Clinical Classifications Software Refined (CCSR) for ICD-10-CM Diagnoses. Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality.
Related Codes
Same clinical process (MS-DRG)
Acts as MCC — raises the severity of other admissions. CMS groups these diagnoses into one MS-DRG principal-diagnosis exclusion process — a CC/MCC on this list never raises severity when the principal diagnosis is also on it.
D59.9 — Acquired hemolytic anemia, unspecified, D60.0 — Chronic acquired pure red cell aplasia, D60.1 — Transient acquired pure red cell aplasia, D60.8 — Other acquired pure red cell aplasias, D60.9 — Acquired pure red cell aplasia, unspecified, D61.01 — Constitutional (pure) red blood cell aplasia, D61.02 — Shwachman-Diamond syndrome, D61.03 — Fanconi anemia, D61.09 — Other constitutional aplastic anemia, D61.1 — Drug-induced aplastic anemia, D61.3 — Idiopathic aplastic anemia, D61.810 — Antineoplastic chemotherapy induced pancytopenia, D61.811 — Other drug-induced pancytopenia, D61.818 — Other pancytopenia, D61.82 — Myelophthisis, D61.89 — Other specified aplastic anemias and other bone marrow failure syndromes, D61.9 — Aplastic anemia, unspecified, D62 — Acute posthemorrhagic anemia, D64.0 — Hereditary sideroblastic anemia, D64.2 — Secondary sideroblastic anemia due to drugs and toxins, +89 more
Same CMS-HCC risk category (V28)
CMS maps these diagnoses to the same Hierarchical Condition Category (Acquired Hemolytic, Aplastic, and Sideroblastic Anemias) for risk-adjusted payment.
D59.6 — Hemoglobinuria due to hemolysis from other external causes, D59.8 — Other acquired hemolytic anemias, D59.9 — Acquired hemolytic anemia, unspecified, D60.0 — Chronic acquired pure red cell aplasia, D60.8 — Other acquired pure red cell aplasias, D60.9 — Acquired pure red cell aplasia, unspecified, D61.01 — Constitutional (pure) red blood cell aplasia, D61.02 — Shwachman-Diamond syndrome, D61.03 — Fanconi anemia, D61.09 — Other constitutional aplastic anemia, D61.3 — Idiopathic aplastic anemia, D61.818 — Other pancytopenia, D61.82 — Myelophthisis, D61.89 — Other specified aplastic anemias and other bone marrow failure syndromes, D64.0 — Hereditary sideroblastic anemia, D64.1 — Secondary sideroblastic anemia due to disease, D64.3 — Other sideroblastic anemias, D64.4 — Congenital dyserythropoietic anemia, P55.0 — Rh isoimmunization of newborn, P55.1 — ABO isoimmunization of newborn, +16 more
Same clinical category (CCSR)
AHRQ's Clinical Classifications Software groups these diagnoses under the same clinical categories (Drug induced or toxic related condition, Aplastic anemia).
D59.2 — Drug-induced nonautoimmune hemolytic anemia, D60.0 — Chronic acquired pure red cell aplasia, D60.1 — Transient acquired pure red cell aplasia, D60.8 — Other acquired pure red cell aplasias, D60.9 — Acquired pure red cell aplasia, unspecified, D61.01 — Constitutional (pure) red blood cell aplasia, D61.02 — Shwachman-Diamond syndrome, D61.03 — Fanconi anemia, D61.09 — Other constitutional aplastic anemia, D61.1 — Drug-induced aplastic anemia, D61.3 — Idiopathic aplastic anemia, D61.810 — Antineoplastic chemotherapy induced pancytopenia, D61.811 — Other drug-induced pancytopenia, D61.818 — Other pancytopenia, D61.82 — Myelophthisis, D61.89 — Other specified aplastic anemias and other bone marrow failure syndromes, D61.9 — Aplastic anemia, unspecified, D63.0 — Anemia in neoplastic disease, D63.1 — Anemia in chronic kidney disease, D63.8 — Anemia in other chronic diseases classified elsewhere, +251 more
Same Index main term, other category
The ICD-10-CM Index to Diseases and Injuries files this code under the main term “Anemia”; these codes share that main term but sit in a different category of the Tabular List.
D59.19 — Other autoimmune hemolytic anemia (Lederer's), D59.2 — Drug-induced nonautoimmune hemolytic anemia (hemolytic, due to, drugs), D59.4 — Other nonautoimmune hemolytic anemias (hemolytic, toxic), D59.6 — Hemoglobinuria due to hemolysis from other external causes (hemolytic, acquired, with hemoglobinuria NEC), D59.8 — Other acquired hemolytic anemias (hemolytic, acquired, specified type NEC), D59.9 — Acquired hemolytic anemia, unspecified (hemolytic, acute), D60.0 — Chronic acquired pure red cell aplasia (aplastic, red cell, chronic), D60.1 — Transient acquired pure red cell aplasia (aplastic, red cell, transient), D60.8 — Other acquired pure red cell aplasias (aplastic, red cell, specified type NEC), D60.9 — Acquired pure red cell aplasia, unspecified (pure red cell), D62 — Acute posthemorrhagic anemia (blood loss, acute), D63.0 — Anemia in neoplastic disease (in, neoplastic disease), D63.1 — Anemia in chronic kidney disease (in, failure, kidney), D63.8 — Anemia in other chronic diseases classified elsewhere (intertropical), D64.0 — Hereditary sideroblastic anemia (sideroblastic, hereditary), D64.1 — Secondary sideroblastic anemia due to disease (sideroblastic, secondary, disease), D64.2 — Secondary sideroblastic anemia due to drugs and toxins (sideroblastic, secondary, drugs and toxins), D64.3 — Other sideroblastic anemias (sideroblastic), D64.4 — Congenital dyserythropoietic anemia (dyshematopoietic), D64.81 — Anemia due to antineoplastic chemotherapy (due to, antineoplastic chemotherapy), +66 more
Contextual Map
Every relationship of D61.2 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Run D61.2 with these 17 related codes in Claim Check
Hierarchy
- D50-D89 — Chapter 3: Diseases of the Blood and Blood-forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89) (D50-D89)[Hierarchy]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
- D60-D64 — Aplastic and other anemias and other bone marrow failure syndromes[Hierarchy]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
Code First (15)
- T51 — Toxic effect of alcohol[Code First]: “, if applicable, toxic effects of substances chiefly nonmedicinal as to source (T51-T65)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
- T52 — Toxic effect of organic solvents[Code First]: “, if applicable, toxic effects of substances chiefly nonmedicinal as to source (T51-T65)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
- T53 — Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbons[Code First]: “, if applicable, toxic effects of substances chiefly nonmedicinal as to source (T51-T65)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
- T54 — Toxic effect of corrosive substances[Code First]: “, if applicable, toxic effects of substances chiefly nonmedicinal as to source (T51-T65)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
- T55 — Toxic effect of soaps and detergents[Code First]: “, if applicable, toxic effects of substances chiefly nonmedicinal as to source (T51-T65)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
- T56 — Toxic effect of metals[Code First]: “, if applicable, toxic effects of substances chiefly nonmedicinal as to source (T51-T65)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
- T57 — Toxic effect of other inorganic substances[Code First]: “, if applicable, toxic effects of substances chiefly nonmedicinal as to source (T51-T65)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
- T58 — Toxic effect of carbon monoxide[Code First]: “, if applicable, toxic effects of substances chiefly nonmedicinal as to source (T51-T65)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
- and 7 more
Referenced by Excludes1 notes
- R71 — Abnormality of red blood cells[Excludes1](via D61.-): “anemias (D50-D64)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
Referenced by Code First instructions (23)
- I21.A1 — Myocardial infarction type 2[Code First](via D61.-): “anemia (D50.0-D64.9)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
- M90.5 — Osteonecrosis in diseases classified elsewhere[Code First](via D61.-): “hemoglobinopathy (D50-D64)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
- T36 — Poisoning by, adverse effect of and underdosing of systemic antibiotics[Code First](via D61.-): “blood disorders (D56-D76)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
- T36-T39 — Antibiotics & Anti-infectives (T36-T39)[Code First](via D61.-): “blood disorders (D56-D76)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
- T36-T50 — Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50)[Code First](via D61.-): “blood disorders (D56-D76)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
- T37 — Poisoning by, adverse effect of and underdosing of other systemic anti-infectives and antiparasitics[Code First](via D61.-): “blood disorders (D56-D76)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
- T38 — Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified[Code First](via D61.-): “blood disorders (D56-D76)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
- T39 — Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics[Code First](via D61.-): “blood disorders (D56-D76)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2027
- and 15 more
Clinical classification (CCSR)
- INJ030 — Drug induced or toxic related condition[CCSR]— AHRQ CCSR for ICD-10-CM Diagnoses (HCUP)
- BLD003 — Aplastic anemia[CCSR]— AHRQ CCSR for ICD-10-CM Diagnoses (HCUP)
Risk adjustment (CMS-HCC)
- HCC 109 — Acquired Hemolytic, Aplastic, and Sideroblastic Anemias [CMS-HCC]— CMS-HCC V28 · 2026
MS-DRG Grouper
- MCC — Major Complication or Comorbidity [MS-DRG severity]: “As a secondary diagnosis this code can raise the stay's MS-DRG severity tier (MCC).”— CMS MS-DRG Definitions Manual (Appendix C) · FY2027
- DRG 808 — MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MCC[MS-DRG]: “MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MCC (MDC 16)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2027
- DRG 809 — MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH CC[MS-DRG]: “MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH CC (MDC 16)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2027
- DRG 810 — MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT CC/MCC[MS-DRG]: “MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT CC/MCC (MDC 16)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2027
MDC crossing
- MDC 16 — Diseases and Disorders of Blood, Blood Forming Organs and Immunologic Disorders[MDC crossing]: “Diseases and Disorders of Blood, Blood Forming Organs and Immunologic Disorders — the grouper's crossing between diagnoses and procedures: a principal diagnosis sets the MDC, and same-MDC procedures move the stay to its surgical DRGs. 1,615 same-MDC procedures group here; browse them on the MDC page.”— CMS MS-DRG Definitions Manual · FY2027
Index entries
- Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound), aplastic, due to, external agents NEC[Index term]— CMS ICD-10-CM Index to Diseases and Injuries · icd10cm-fy2027
- Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound), aplastic, due to, infection[Index term]— CMS ICD-10-CM Index to Diseases and Injuries · icd10cm-fy2027
- Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound), aplastic, due to, radiation[Index term]— CMS ICD-10-CM Index to Diseases and Injuries · icd10cm-fy2027
- Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound), aplastic, toxic[Index term]— CMS ICD-10-CM Index to Diseases and Injuries · icd10cm-fy2027
- Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound), toxic[Index term]— CMS ICD-10-CM Index to Diseases and Injuries · icd10cm-fy2027
Nearest codes (16)
- D61 — Other aplastic anemias and other bone marrow failure syndromes[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
- D61.0 — Constitutional aplastic anemia[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
- D61.01 — Constitutional (pure) red blood cell aplasia[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
- D61.02 — Shwachman-Diamond syndrome[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
- D61.03 — Fanconi anemia[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
- D61.09 — Other constitutional aplastic anemia[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
- D61.1 — Drug-induced aplastic anemia[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
- D61.3 — Idiopathic aplastic anemia[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2027
- and 8 more
Change history
- FY2016 — In the code set at ICD-10-CM adoption [Change history]— CMS release files (code change ledger) · icd10cm-fy2016
Reference
Index terms and tables, published questions and FAQ, every source behind this page with its release and checksum, the date-of-service check and the complete change history.
Indexed Clinical Terms (5)
Official source data — entries quoted as published, in the Index’s own lookup phrasing
Clinical term phrases from the official ICD-10-CM Index to Diseases and Injuries that map to this code. These are alphabetic-index entries shown as the Index writes them — lookup phrasing, not necessarily the wording of a final diagnosis.
- Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound), aplastic, due to, external agents NEC
- Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound), aplastic, due to, infection
- Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound), aplastic, due to, radiation
- Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound), aplastic, toxic
- Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound), toxic
Sources for this page
Codes, titles, notes, index terms and mappings on this page are transcribed from the datasets below. Relationships MedCoder computed and text MedCoder wrote are labelled where they appear.
- Code, title, tabular notes and index terms Official source data
- CMS/CDC ICD-10-CM FY2027 tabular list, index and tables, effective October 1, 2026 Release, file and checksum · Publisher’s page
- Coding guidelines Official source data
- ICD-10-CM Official Guidelines for Coding and Reporting (FY2027), quoted by section Release, file and checksum · Publisher’s page
- Claim edits Official source data
- CMS Definitions of Medicare Code Edits — v44.0 (October 2026) Release, file and checksum · Publisher’s page
- Inpatient payment groups Official source data
- CMS MS-DRG Definitions Manual (incl. Appendix B diagnosis index, Appendix C CC/MCC list, Appendix E procedure index) and IPPS Final Rule tables — v44 Release, file and checksum · Publisher’s page
- Risk adjustment Official source data
- 2026 Mid-Year Final ICD-10 Mappings + Model Software (cms.gov/files/zip/2026-midyear-final-icd-10-mappings.zip, 2026-midyear-final-model-software.zip) — CMS-HCC V28, PY2026 mid-year final release Release, file and checksum · Publisher’s page
- Change history and date-of-service validity Official source data
- CMS ICD-10-CM release addenda, ingested release by release into the change ledger Release, file and checksum · Publisher’s page
- Comparisons, relationships and the contextual map MedCoder-derived relationship
- Computed by MedCoder from the tabular notes and tables above; every derived relationship is marked as derived where it appears
- Summary and FAQ answers MedCoder editorial explanation
- Written by MedCoder to explain the sources above: drafted with AI assistance, checked by a person against the release files, and labelled as MedCoder text where it appears. Not official text.
Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources
Labels on this page: Official source data · MedCoder-derived relationship · MedCoder editorial explanation. How to read the labels · All data sources and release dates · CMS coding rules
Cite this page
Reference this page in a research guide, syllabus or article. The release is included because code content changes each year.
MedCoder.ai. "D61.2 — Aplastic anemia due to other external agents." ICD-10-CM FY2027. https://medcoder.ai/icd10/code/d61.2-aplastic-anemia-due-to-other-external-agents
Change history
- FY2016 — October 1, 2015In the code set at ICD-10-CM adoptionAplastic anemia due to other external agents
No changes since FY2016 — additions, deletions, description changes and billable-status changes are tracked through FY2027, and none are recorded for this code. Note changes are tracked from FY2027 only.
Nearest Codes in This Family
Official ICD-10-CM classifications closest to D61.2 in its code family, with their registry titles.
- D61.01 — Constitutional (pure) red blood cell aplasia
- D61.02 — Shwachman-Diamond syndrome
- D61.03 — Fanconi anemia
- D61.09 — Other constitutional aplastic anemia
- D61.1 — Drug-induced aplastic anemia
- D61.3 — Idiopathic aplastic anemia
- D61.8 — Other specified aplastic anemias and other bone marrow failure syndromes
- D61.81 — Pancytopenia
- D61.810 — Antineoplastic chemotherapy induced pancytopenia
- D61.811 — Other drug-induced pancytopenia